1. Home
  2. QDEL vs KURA Comparison

QDEL vs KURA Comparison

Compare QDEL & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

N/A

Current Price

$10.73

Market Cap

989.5M

Sector

Health Care

ML Signal

N/A

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

N/A

Current Price

$7.70

Market Cap

912.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QDEL
KURA
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
989.5M
912.7M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
QDEL
KURA
Price
$10.73
$7.70
Analyst Decision
Hold
Strong Buy
Analyst Count
3
16
Target Price
$15.00
★ $32.00
AVG Volume (30 Days)
★ 2.2M
2.2M
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.35
N/A
EPS
N/A
★ N/A
Revenue
★ $2,730,200,000.00
$67,482,000.00
Revenue This Year
N/A
$33.60
Revenue Next Year
N/A
$122.30
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 25.24
52 Week Low
$9.92
$6.75
52 Week High
$35.58
$13.90

Technical Indicators

Market Signals
Indicator
QDEL
KURA
Relative Strength Index (RSI) 37.87 36.55
Support Level $10.49 $7.36
Resistance Level $18.15 $9.82
Average True Range (ATR) 1.25 0.79
MACD -0.37 -0.12
Stochastic Oscillator 7.55 23.54

Price Performance

Historical Comparison
QDEL
KURA

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: